BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7754629)

  • 1. Patient selection and treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer.
    Sugarbaker PH
    World J Surg; 1995; 19(2):235-40. PubMed ID: 7754629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic features for peritoneal carcinomatosis in colorectal and appendiceal cancer patients when treated by cytoreductive surgery and intraperitoneal chemotherapy.
    Sugarbaker PH; Chang D; Koslowe P
    Cancer Treat Res; 1996; 81():89-104. PubMed ID: 8834578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy.
    Sugarbaker PH; Jablonski KA
    Ann Surg; 1995 Feb; 221(2):124-32. PubMed ID: 7857141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management.
    Pestieau SR; Sugarbaker PH
    Dis Colon Rectum; 2000 Oct; 43(10):1341-6; discussion 1347-8. PubMed ID: 11052509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
    Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma.
    Piso P; Bektas H; Werner U; Schlitt HJ; Kubicka S; Bornscheuer A; Manns M; Klempnauer J
    Eur J Surg Oncol; 2001 Apr; 27(3):286-90. PubMed ID: 11373107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary cytoreductive surgery and peri-operative intraperitoneal chemotherapy for peritoneal recurrence of colorectal and appendiceal peritoneal carcinomatosis following prior primary cytoreduction.
    Klaver YL; Chua TC; Verwaal VJ; de Hingh IH; Morris DL
    J Surg Oncol; 2013 May; 107(6):585-90. PubMed ID: 23280508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sites of Recurrence After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis from Colorectal and Appendiceal Adenocarcinoma: A Tertiary Center Experience.
    Feferman Y; Solomon D; Bhagwandin S; Kim J; Aycart SN; Feingold D; Sarpel U; Labow DM
    Ann Surg Oncol; 2019 Feb; 26(2):482-489. PubMed ID: 30539491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful management of microscopic residual disease in large bowel cancer.
    Sugarbaker PH
    Cancer Chemother Pharmacol; 1999; 43 Suppl():S15-25. PubMed ID: 10357554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse Events Postoperatively Had No Impact on Long-Term Survival of Patients Treated with Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Appendiceal Cancer with Peritoneal Metastases.
    Ihemelandu C; Mavros MN; Sugarbaker P
    Ann Surg Oncol; 2016 Dec; 23(13):4231-4237. PubMed ID: 27338748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeat Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancy and Peritoneal Carcinomatosis.
    Wong JF; Tan GH; Wang W; Soo KC; Teo MC
    World J Surg; 2015 Jun; 39(6):1578-83. PubMed ID: 25651962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal surface oncology: review of a personal experience with colorectal and appendiceal malignancy.
    Sugarbaker PH
    Tech Coloproctol; 2005 Jul; 9(2):95-103. PubMed ID: 16007367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal and appendiceal origin].
    Berger Y; Zbar AP; Lebedyev A; Levi Y; Nevler A; Aderka D; Golan T; Purim O; Brenner B; Natur M; Gutman M
    Harefuah; 2014 Jun; 153(6):315-9, 368. PubMed ID: 25095601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from colorectal or appendiceal mucinous neoplasms.
    Bijelic L; Yan TD; Sugarbaker PH
    J Surg Oncol; 2008 Sep; 98(4):295-9. PubMed ID: 18726900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal carcinomatosis from appendiceal cancer: results in 69 patients treated by cytoreductive surgery and intraperitoneal chemotherapy.
    Sugarbaker PH; Zhu BW; Sese GB; Shmookler B
    Dis Colon Rectum; 1993 Apr; 36(4):323-9. PubMed ID: 8458256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients.
    Baratti D; Kusamura S; Iusco D; Bonomi S; Grassi A; Virzì S; Leo E; Deraco M
    Dis Colon Rectum; 2014 Jul; 57(7):858-68. PubMed ID: 24901687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.
    Koppe MJ; Boerman OC; Oyen WJ; Bleichrodt RP
    Ann Surg; 2006 Feb; 243(2):212-22. PubMed ID: 16432354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer by extensive cytoreductive surgery combined with hyperthermic intraoperative intraperitoneal chemotherapy].
    Legendre H; Delaunoit T; Chassaing C; Pector JC
    Rev Med Brux; 2005; 26(5):439-44. PubMed ID: 16318097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer.
    Carmignani CP; Ortega-Perez G; Sugarbaker PH
    Eur J Surg Oncol; 2004 May; 30(4):391-8. PubMed ID: 15063892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraperitoneal-Free Cancer Cells Represent a Major Prognostic Factor in Colorectal Peritoneal Carcinomatosis.
    Trilling B; Cotte E; Vaudoyer D; Isaac S; Piaton E; Maurice C; Glehen O; Passot G
    Dis Colon Rectum; 2016 Jul; 59(7):615-22. PubMed ID: 27270513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.